Published in IEEE Trans Med Imaging on December 01, 1997
Deformable medical image registration: a survey. IEEE Trans Med Imaging (2013) 2.48
Left ventricular motion reconstruction from planar tagged MR images: a comparison. Phys Med Biol (2000) 1.40
Three-dimensional motion tracking of coronary arteries in biplane cineangiograms. IEEE Trans Med Imaging (2003) 1.15
Evaluating Similarity Measures for Brain Image Registration. J Vis Commun Image Represent (2013) 0.83
Automatic PET-CT image registration method based on mutual information and genetic algorithms. ScientificWorldJournal (2012) 0.80
Is it Feasible to Use the Commercially Available Autoquantitation Software for the Evaluation of Myocardial Viability on Small-Animal Cardiac F-18 FDG PET Scan? Nucl Med Mol Imaging (2013) 0.76
Spillover Compensation in the Presence of Respiratory Motion Embedded in SPECT Perfusion Data. IEEE Trans Nucl Sci (2008) 0.75
Registration of coronary arteries in computed tomography angiography images using Hidden Markov Model. Conf Proc IEEE Eng Med Biol Soc (2015) 0.75
Normal Databases for the Relative Quantification of Myocardial Perfusion. Curr Cardiovasc Imaging Rep (2016) 0.75
Analysis of carotid artery deformation in different head and neck positions for maxillofacial catheter navigation in advanced oral cancer treatment. Biomed Eng Online (2012) 0.75
Registration of 3D CT angiography and cardiac MR images in coronary artery disease patients. Int J Cardiovasc Imaging (2003) 0.75
Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam irradiation. Radiother Oncol (1992) 1.57
Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. Clin Cancer Res (1996) 1.47
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer. Clin Cancer Res (2000) 1.30
Definition of a four-dimensional continuous planispheric transformation for the tracking and the analysis of left-ventricle motion. Med Image Anal (1998) 1.16
The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients. Cancer (1981) 1.08
Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am Heart J (1983) 1.07
Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol (1979) 1.07
Applications of ventilation lung imaging with 81mKrypton. Radiology (1977) 1.06
Detection, quantitation and pathophysiology of lung "spiders". Trans Assoc Am Physicians (1975) 1.05
Bone marrow regeneration following large field radiation: influence of volume, age, dose, and time. Cancer (1978) 0.96
Interpolative background subtraction. J Nucl Med (1976) 0.94
Thallium-201 myocardial imaging in patients with previous cardiac transplantation. Clin Radiol (1981) 0.94
Detection of occult abscesses with 111In-labeled leukocytes. AJR Am J Roentgenol (1979) 0.93
Noninvasive assessment of donor and native heart function after heterotopic heart transplantation. J Thorac Cardiovasc Surg (1988) 0.92
In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration. J Nucl Med (1975) 0.91
Myocardial imaging in a patient with reproducible variant angina. Am J Cardiol (1977) 0.90
Changes in rest and exercise myocardial perfusion and left ventricular function 3 to 26 weeks after clinically uncomplicated acute myocardial infarction: effects of exercise training. Am J Cardiol (1984) 0.90
Interhemispheric asymmetry of regional cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder. Nucl Med Commun (2001) 0.90
Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris. Am J Cardiol (1977) 0.88
A shunt is (not) a shunt is (not) a shunt. Am Rev Respir Dis (1977) 0.87
Cardiovascular physiology in a case of heterotopic cardiac transplantation. Am J Cardiol (1982) 0.85
Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin. Cancer Biother Radiopharm (1999) 0.85
A fully automated determination of the left ventricular region of interest in nuclear angiocardiography. Cardiovasc Intervent Radiol (1981) 0.84
Correlation of tumor sensitivity to low-dose-rate irradiation with G2/M-phase block and other radiobiological parameters. Radiat Res (1993) 0.83
In vivo imaging of acute cardiac rejection in human patients using (99m)technetium labeled annexin V. Am J Transplant (2001) 0.81
Mechanisms for decreased exercise capacity after bed rest in normal middle-aged men. Am J Cardiol (1983) 0.81
Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts. Cancer Res (1993) 0.81
Improved specificity of prone versus supine thallium SPECT imaging. Clin Nucl Med (1988) 0.81
Determinants of the antitumor effect of radiolabeled monoclonal antibodies. Cancer Res (1990) 0.79
Parathyroid imaging. Use of dual isotope scintigraphy for the localization of adenomas before surgery. Clin Nucl Med (1992) 0.78
99Technetium bone scanning in experimental osteomyelitis. Clin Orthop Relat Res (1977) 0.78
Vesicle interactions with polyamino acids and antibody: in vitro and in vivo studies. J Nucl Med (1975) 0.78
Diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study. Acta Pharmacol Toxicol (Copenh) (1985) 0.78
Failure to diagnose cardiac treatment rejection with Tc99m-PYP images. Clin Nucl Med (1981) 0.78
Pyrophosphate retention by previously irradiated renal tissue. Radiology (1979) 0.78
MRI of pulmonary embolism using Gd-DTPA-polyethylene glycol polymer enhanced 3D fast gradient echo technique in a canine model. Magn Reson Imaging (1997) 0.77
Maxillary-facial abnormalities assessed by bone imaging. Radiology (1976) 0.76
Skeletal scintigraphy for the diagnosis of malignant metastatic disease to the bones. Radiother Oncol (1985) 0.76
Krypton-81m ventilation scintigraphy for the diagnosis of pulmonary emboli. Clin Nucl Med (1981) 0.75
Pulmonary SPECT imaging and the stripe sign. J Nucl Med (1998) 0.75
Of theoretical derivations and empirical evidence. J Nucl Med (1992) 0.75
Cost containment in Oregon: as simple as A x B? JAMA (1992) 0.75
Nuclear Medicine: Lung Scanning and the Detection of Pulmonary Emboli: Combined 81m-Krypton Ventilation/99m-Tc-macroaggregate Perfusion Scintigraphy. West J Med (1977) 0.75
Diuretic renography. J Nucl Med (1993) 0.75
Intense concentration of technetium-99m pyrophosphate in the kidneys of children treated with chemotherapeutic drugs for malignant disease. Radiology (1978) 0.75
Reliability and reproducibility of interpretation of 99mtechnetium pyrophosphate myocardial scintigrams. Clin Cardiol (1979) 0.75
Computers in nuclear medicine. Adm Radiol (1989) 0.75
Bone scintigraphy in osteomyelitis. J Nucl Med (1986) 0.75
Scintigraphic evaluation of pulmonary ventilation. Clin Nucl Med (1982) 0.75
[Preliminary evaluation of the effect of an attenuation correction method in myocardial perfusion SPECT]. Rev Esp Med Nucl (1999) 0.75
Nuclear medicine: more than just medical imaging. J Nucl Med (1993) 0.75
ECG gating of thallium-201 myocardial images: effect on detection of ischemic heart disease. J Nucl Med (1981) 0.75
A stochastic interpretation of thallium myocardial perfusion scintigraphy. Invest Radiol (1985) 0.75
Re: "abnormal" response of ejection fraction caused by region-of-interest selection. J Nucl Med (1981) 0.75
The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts. Int J Radiat Oncol Biol Phys (1994) 0.75
Sequential equilibrium gated radionuclide angiocardiography for the detection of doxorubicin cardiotoxicity. Radiother Oncol (1983) 0.75
The role of In-111 leukocyte scanning in pyoderma gangrenosum. Clin Nucl Med (1981) 0.75
Considerations in the purchase of a nuclear medicine computer system. J Nucl Med (1988) 0.75
Value of 111Indium chloride bone marrow scanning in the differential diagnosis of blood count depression in lymphoma. Cancer (1978) 0.75
Long-term scintigraphic appearance of extremities following bone tumor resection and allograft reconstruction. Clin Nucl Med (1991) 0.75
Photopenic lesions in bone scintigraphy. Clin Nucl Med (1980) 0.75
123I-iodo-bromsulphalein as a liver and biliary scanning agent. J Nucl Med (1973) 0.75
A method to optimise the use of a grayshade scale in nuclear medicine images. Comput Biomed Res (1976) 0.75
Scintigraphic evaluation of coronary artery disease. Compr Ther (1980) 0.75
X-ray angiography in stereotactic conditions: techniques and interest for interventional neuroradiology. Stereotact Funct Neurosurg (1997) 0.75
In vivo distribution of vesicles loaded with radiopharmaceuticals: a comparison of different routes of administration. Scott Med J (1975) 0.75
A thresholding for radionuclide angiocardiography. Invest Radiol (1981) 0.75
Indium bone marrow scintigraphy as an aid in selecting marrow biopsy sites for the evaluation of marrow elements in patients with lymphoma. Cancer (1976) 0.75
Functional or parametric images. J Nucl Med (1982) 0.75
Nontarget activities: can we correct for them? J Nucl Med (1979) 0.75
Parametric images as a tool for quantitative normative evaluation. Semin Nucl Med (1987) 0.75
The biodistribution of 111In-anti-bFGF in a variety of tumors. Correlation with cell-binding assays. Ann N Y Acad Sci (1991) 0.75
The effect of unlabelled monoclonal antibody (mAb) on the biodistribution of 131I-anti-idiotype mAb in murine B cell lymphoma. Radiother Oncol (1992) 0.75
Suitability of radiopharmaceuticals for determining right-to-left shunting: concise communication. J Nucl Med (1977) 0.75
Myocardial imaging the thallium-201. J Nucl Med (1978) 0.75
The accuracy of 111InCl3 as a bone marrow scanning agent. Radiology (1976) 0.75